Ивабрадин Viatris

Ivabradine Oxalate is a heart rate-regulating medication used to reduce heart rate in adults with chronic stable angina or heart failure. It helps improve exercise capacity and reduce symptoms. This EU-sourced oral treatment is available as Ivabradine Viatris.

Ivabradine Oxalate is primarily used to manage chronic stable angina pectoris in adults with normal sinus rhythm who cannot tolerate beta-blockers. It is also prescribed for symptomatic heart failure with reduced ejection fraction in patients who are in sinus rhythm and whose heart rate is above 70 beats per minute. The medication helps reduce heart rate, improving symptoms and exercise tolerance. It is not intended for acute symptom relief or emergency situations.

Ivabradine Oxalate works by selectively inhibiting the cardiac pacemaker current (If), which helps slow the heart rate without affecting blood pressure or contractility. Users may notice improved ability to perform physical activities and reduced episodes of chest pain. Some individuals report mild visual effects, such as temporary brightness in the visual field, which are generally transient.

This medication should be taken exactly as prescribed, typically twice daily with food. It is important to monitor heart rate regularly and report any persistent symptoms or side effects to a healthcare provider. Patients with certain heart rhythm disorders, low blood pressure, or severe liver problems should use this medication with caution. Avoid abrupt discontinuation unless directed by a doctor.

Ivabradine Oxalate may interact with other heart medications, particularly those that lower heart rate or affect heart rhythm, such as beta-blockers, calcium channel blockers, or digoxin. Strong CYP3A4 inhibitors, including certain antifungals and antibiotics, can increase ivabradine levels in the blood, requiring dose adjustments. Grapefruit juice should be avoided due to potential interactions. Always inform your healthcare provider about all medications and supplements being taken.